110 related articles for article (PubMed ID: 6666223)
21. Isosorbide dinitrate bioavailability, kinetics, and metabolism.
Straehl P; Galeazzi RL
Clin Pharmacol Ther; 1985 Aug; 38(2):140-9. PubMed ID: 4017416
[TBL] [Abstract][Full Text] [Related]
22. Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man.
Laufen H; Aumann M; Leitold M
Arzneimittelforschung; 1983; 33(7):980-4. PubMed ID: 6684933
[TBL] [Abstract][Full Text] [Related]
23. [Bioavailability of sustained-release and nonsustained-release isosorbide-5-mononitrate].
Muck B; Bonn R; Rietbrock N
Arzneimittelforschung; 1989 Oct; 39(10):1274-6. PubMed ID: 2610720
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacokinetic profile and bioavailability of a new pharmaceutical formulation of isosorbide-5-mononitrate sustained-release formulation].
Skutta T; Böttcher B; Brandt L
Arzneimittelforschung; 1989 Apr; 39(4):507-11. PubMed ID: 2751738
[TBL] [Abstract][Full Text] [Related]
25. [Pharmacokinetics of 14C-isosorbide dinitrate after administration in various sustained-release formulations].
Chasseaud LF; Taylor T; Major RM; Taylor IW; Luckow V; Darragh A; Lambe RF
Arzneimittelforschung; 1983; 33(9):1298-301. PubMed ID: 6685511
[TBL] [Abstract][Full Text] [Related]
26. Bioequivalence of a sustained-release isosorbide dinitrate formulation at steady-state.
Taylor T; Chasseaud LF; Major RM; Leaf FC; Bonn R; Darragh A; Lambe RF
Biopharm Drug Dispos; 1985; 6(2):119-29. PubMed ID: 4005392
[TBL] [Abstract][Full Text] [Related]
27. Oral isosorbide-5-mononitrate: pharmacokinetics and clinical efficacy.
Kanto JH
Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):129-35. PubMed ID: 3557738
[TBL] [Abstract][Full Text] [Related]
28. [Pharmacokinetics of isosorbide dinitrate administered by intravenous infusion to hypertensive patients (author's transl)].
Frydman A; Levenson J; Simon A; Safar M; Bieder A; Bertharion J; Gaillot J
Nouv Presse Med; 1982 Jun; 11(27):2049-56. PubMed ID: 7110964
[TBL] [Abstract][Full Text] [Related]
29. Plasma concentrations and bioavailability of isosorbide dinitrate and pindolol from a combination formulation.
Chasseaud LF; Doyle E; Taylor T; Darragh A
Biopharm Drug Dispos; 1981; 2(3):273-81. PubMed ID: 7295884
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of isosorbide mononitrate in a new sustained release oral form in comparison with a conventional formulation.
Gandini R; Cunietti E; Assereto R; Castoldi D; Tofanetti O; Baggio E
Arzneimittelforschung; 1987 Jul; 37(7):836-9. PubMed ID: 3675680
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and pharmacodynamics of isosorbide dinitrate.
Fung HL
Am Heart J; 1985 Jul; 110(1 Pt 2):213-6. PubMed ID: 4013997
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of intravenous isosorbide-dinitrate.
Platzer R; Reutemann G; Galeazzi RL
J Pharmacokinet Biopharm; 1982 Dec; 10(6):575-86. PubMed ID: 7182455
[TBL] [Abstract][Full Text] [Related]
33. Bioavailability and metabolism of isosorbide dinitrate from a transdermal spray.
Laufen H; Leitold M
Arzneimittelforschung; 1992 Jul; 42(7):931-5. PubMed ID: 1418058
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of intravenous and oral isosorbide - 5 - mononitrate.
Abshagen U; Betzien G; Endele R; Kaufmann B
Eur J Clin Pharmacol; 1981; 20(4):269-75. PubMed ID: 7308280
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and pharmacodynamics of organic nitrates.
Fung HL
Am J Cardiol; 1987 Nov; 60(15):4H-9H. PubMed ID: 3120565
[TBL] [Abstract][Full Text] [Related]
36. First data on effects and pharmacokinetics of isosorbide-5-mononitrate in normal man.
Abshagen U; Spörl-Radun S
Eur J Clin Pharmacol; 1981; 19(6):423-9. PubMed ID: 7250175
[TBL] [Abstract][Full Text] [Related]
37. Metabolic fact of 14C-isosorbide 5-mononitrate in humans.
Wood SG; John BA; Chasseaud LF; Major RM; Forrest ME; Bonn R; Darragh A; Lambe RF
Arzneimittelforschung; 1984; 34(9):1031-5. PubMed ID: 6542370
[TBL] [Abstract][Full Text] [Related]
38. The effect of food on the oral absorption of isosorbide-5-mononitrate.
Laufen H; Leitold M
Br J Clin Pharmacol; 1984 Dec; 18(6):967-8. PubMed ID: 6529537
[No Abstract] [Full Text] [Related]
39. Fate of isosorbide dinitrate and mononitrates in patients with renal failure.
Bogaert MG; Rosseel MT; Boelaert J; Daneels R
Eur J Clin Pharmacol; 1981; 21(1):73-6. PubMed ID: 7333349
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacokinetics, effect and tolerance of isosorbide dinitrate and isosorbide-5-mononitrate in healthy persons].
Abshagen U; Spörl-Radun S; Betzien G; Kaufmann B; Endele R
Med Welt; 1981 Apr; 32(14A):508-16. PubMed ID: 7242310
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
